Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer
NCT04987931
·
clinicaltrials.gov ↗
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Talazoparib
Sponsor
Pfizer